We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy

By HospiMedica International staff writers
Posted on 04 May 2022

A scientific e-poster presented during the 2022 ARRS Annual Meeting in Los Angeles, USA discussed how to prevent contamination and spread of COVID-19 during nuclear medicine ventilation/perfusion scintigraphy (V/Q) by modifying to lung perfusion scintigraphy only. More...

The retrospective study by researchers at Rush University Medical Center (Chicago, IL, USA) included a comparison of lung perfusion scintigraphy during the COVID-19 pandemic (April 2020 to July 2021) to the V/Q scans performed during immediate pre-COVID era (December 2018 to March 2020) in a large tertiary care teaching hospital. Instead of the ventilation scan, chest radiographs or CT scans performed within 24 hours were used to correlate lung perfusion findings during the COVID era.

As expected, there was 30% decline (154 less lung scans, 357 total) in the overall number of lung scans performed during the COVID-19 pandemic, compared with the pre-COVID era, where 511 V/Q scans were performed. Out of 511 patients who underwent a V/Q scan pre-COVID, 349 (68.3%) had low, 142 (27.8%) had intermediate, and 20 (3.9%) had a high probability scan for pulmonary embolism (PE). Out of 347 patients who underwent lung perfusion scintigraphy during COVID, 199 (57.3%) had low, 114 (32.9%) had indeterminate scans, and 34 (9.8%) had high probability scans for PE.

“This study provides a comparative analysis of lung perfusion scans performed during the COVID-19 pandemic to V/Q scans performed during the immediate prior pre-COVID era,” said presenting author Pokhra Suthar of Rush University Medical Center. “We compared the probability of scintigraphy scans in terms of low, intermediate, and high probability based on modified PIOPED II and perfusion-only modified PIOPED II criteria.”

Related Links:
Rush University Medical Center 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Hemostatic Agent
HEMOBLAST Bellows
New
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.